Skip to main content
. 2013 Feb;98(2):316–322. doi: 10.3324/haematol.2012.071712

Figure 4.

Figure 4.

Analysis of TCR BV usage by in vitro primed ESO-tetramer+-TH. Conventional naïve CD4+ T cells from healthy donors were stimulated with peptide ESO119-143 as in Figure 1A and Day 12 cultures were stained with DR52b/ESO tetramers and anti-CD4 and anti-BV2 mAb and analyzed by flow cytometry. (A) Examples of dot plots showing tetramer staining versus anti-CD4 staining in the culture and anti-BV2 staining versus tetramer staining gated on CD4+ cells. (B) The proportions of BV2+ cells in total CD4+ cells in the cultures and in ESO-tetramer+ cells are summarized for all donors assessed (n=11). Statistical analyses were performed using Wilcoxon’s matched pairs test. ***P<0.001.